Thangalazhy Gopakumar Sumithra

Thangalazhy Gopakumar Sumithra

Auto-generated profile, based on publicly available information

Thangalazhy Gopakumar Sumithra

ICAR-Central Marine Fisheries Research Institute, Kochi, India

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2013 in European Journal of Wildlife Research
Verified
Journal Article
Closed access
PDF file
TST. G. Sumithra
T. G. Sumithra
VCV. K. Chaturvedi
V. K. Chaturvedi
CSC. Susan
C. Susan
SSS. J. Siju
S. J. Siju
ARA. K. Rai
A. K. Rai
SSS. C. Sunita
S. C. Sunita

6 August 2018 in Aquaculture
Verified
Journal Article
Closed access
KRK.J. Reshma
K.J. Reshma
TST.G. Sumithra
T.G. Sumithra
ANAnusree V. Nair
Anusree V. Nair
VRV. Stefi Raju
V. Stefi Raju
TKT.G. Kishor
T.G. Kishor
NSN.K. Sanil
N.K. Sanil

1 February 2019 in Aquaculture
Verified
Journal Article
Closed access
TST.G. Sumithra
T.G. Sumithra
KRK.J. Reshma
K.J. Reshma
JCJ.P. Christo
J.P. Christo
VAV.N. Anusree
V.N. Anusree
DDD. Drisya
D. Drisya
NSN.K. Sanil
N.K. Sanil

1 August 2021 in Fish & Shellfish Immunology
Verified
Journal Article
Closed access
TST.G. Sumithra
T.G. Sumithra
BNB.R. Neethu
B.R. Neethu
KRK.J. Reshma
K.J. Reshma
VAV.N. Anusree
V.N. Anusree
PRP. Reynold
P. Reynold
NSN.K. Sanil
N.K. Sanil

23 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VLV. P. Lailaja
V. P. Lailaja
TST. G. Sumithra
T. G. Sumithra
SSS. R. Krupesha Sharma
S. R. Krupesha Sharma
MMM. Ashif Mohammed
M. Ashif Mohammed
USUnnikrishnan Sivan
Unnikrishnan Sivan
VAV. N. Anusree
V. N. Anusree
L-asparaginase is a vital antineoplastic drug. The side effects of the current formulations intrigued researchers to explore novel candidates. The study evaluated a novel type-II L-asparaginase from Chryseomicrobium amylolyticum from marine crab, Scylla serrata. Statistical optimization enhanced production to 281.6 from 115.69 IU/ml. The purified enzyme had 173.69 IU/mg protein specific activity. The Km, Vmax, and Kcat were 6.364 µM, 909.09 µM/min, and 222.82 /sec. The enzyme didn’t react with L-glutamine, D-glutamine, L-glutamic acid, and urea, a clinically desirable feature. In vitro trypsin and serum half-life were ~ 39 h and ~ 27 min. The study enlisted ions, protein-modifying agents, and surfactants influencing its activity. The detailed in silico analyses of the functional gene predicted its physicochemical and structural features. The low sequence identity with the commercial enzymes and the predicted nonallergenic and nontoxic features suggested its clinical suitability. Molecular docking revealed a higher binding affinity for L-asparagine than L-glutamine and urea. The IC50 against MCF7, MOLT4 and THP-1 cell lines were 0.043, 0.041, and 0.05 IU/ml, respectively. Phase contrast microscopy confirmed its cytotoxicity. Flow cytometry demonstrated 81.4% apoptotic cells in MOLT-4 cells at IC50, signifying potent anticancer activity. The enzyme did not affect normal human fibroblast cells and was non-haemolytic. The results underscore the therapeutic potential of C. amylolyticum type-II L-asparaginase and support further in vivo studies to advance L-asparaginase-based cancer therapies.

3 April 2020 in Aquaculture Research
Verified
Journal Article
Closed access
PDF file
KRKalarical Janardhanan Reshma
Kalarical Janardhanan Reshma
TSThangalazhy G. Sumithra
Thangalazhy G. Sumithra
BVBalachandran Vishnu
Balachandran Vishnu
RJRaju Jyothi
Raju Jyothi
RKRaveendran Ratheesh Kumar
Raveendran Ratheesh Kumar
NSNandiath K. Sanil
Nandiath K. Sanil